ANIP 55.46 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ANIP 55.46 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high of 55.88 Closing the day 09:44 at 55.46 -0.20 -0.36% With a day low of 54.74 and a total volume of 16,557.

ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/

ANIP ANI Pharmaceuticals Inc Recent Headline News

Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 3 mins ago
Amarin Corporation plc (AMRN) was a big mover last session, as the company saw its shares rise by over 23% on the day.
ANIP: 55.07 (-0.59), AMRN: 1.33 (+0.01), AMAG: 34.87 (-0.47), AFFX: 9.09 (-0.49)

Kite Pharma Gains on Positive Opinion for KTE-C19 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:30PM CST
Kite Pharma (KITE) received a positive opinion from the European Medicines Agency's Committee for Orphan Medicinal Products for granting orphan medicinal product status to KTE-C19.
BIIB: 303.77 (-1.79), KITE: 44.04 (+2.27), ANIP: 55.07 (-0.59), AMAG: 34.87 (-0.47)

Amicus Therapeutics, Inc. (FOLD) in Focus: Stock Soars 17.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 8:21AM CST
Amicus Therapeutics, Inc. (FOLD) was a big mover last session, as the company saw its shares rise by nearly 18% on the day.
ANIP: 55.07 (-0.59), AMAG: 34.87 (-0.47), AFFX: 9.09 (-0.49), FOLD: 6.89 (+0.14)

Celldex Therapeutics, Inc. (CLDX) in Focus: Stock Soars 28.9% - Tale of the Tape
Vaishali Doshi Shah - Zacks Investment Research - Tue Nov 18, 8:18AM CST
Celldex Therapeutics, Inc. (CLDX) was a big mover last session, as the company saw its shares rise by almost 29% on the day.
ANIP: 55.07 (-0.59), CLDX: 18.50 (+0.78), AMAG: 34.87 (-0.47), AFFX: 9.09 (-0.49)

Integra (IART) Strengthens Spinal Implant with Twin Launches - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 2:30PM CST
The latest Interbody and orthobiologic device launches are expected to drive a sequential increase in Integra Lifesciences' (IART) spine sales in the fourth quarter of 2014.
IART: 47.27 (-0.22), ANIP: 55.07 (-0.59), AMAG: 34.87 (-0.47), AFFX: 9.09 (-0.49)

Kite Pharma's Q3 Loss Narrows Y/Y, Focus on Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 9:42AM CST
Kite Pharma, Inc. (KITE) reported third-quarter 2014 loss of $0.24 per share well below the year-ago loss of $37 cents per share.
BIIB: 303.77 (-1.79), KITE: 44.04 (+2.27), ANIP: 55.07 (-0.59), AMAG: 34.87 (-0.47)

Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 7:45AM CST
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 55.07 (-0.59), AMAG: 34.87 (-0.47), AFFX: 9.09 (-0.49), PBYI: 222.26 (-0.74)

Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 303.77 (-1.79), ANIP: 55.07 (-0.59), AMAG: 34.87 (-0.47), AFFX: 9.09 (-0.49)

Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 55.07 (-0.59), ICPT: 158.82 (-3.68), AMAG: 34.87 (-0.47), AFFX: 9.09 (-0.49)

Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 55.07 (-0.59)

ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 55.07 (-0.59), SCMP: 11.67 (-0.38)

Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 55.07 (-0.59)

Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 303.73 (-1.83), ANIP: 55.07 (-0.59), CLDX: 18.50 (+0.78), AMAG: 34.87 (-0.47)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.40 (-0.21), ANIP: 55.07 (-0.59), ACGL: 56.76 (-0.20), ACCO: 8.90 (+0.01), FLWS: 8.59 (-0.06)

ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI" (NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 55.07 (-0.59)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.00 (-0.26), HBNK: 19.88 (-0.45), ASMI: 42.02 (+0.31), RRGB: 66.62 (-0.61), SAPE: 24.66 (+0.01), PLUG: 4.10 (+0.06), ANIP: 55.07 (-0.59), ODP: 6.65 (-0.04), MTEX: 22.33 (+0.66), JAXB: 12.24 (+1.19), ALQA: 4.94 (-0.06), YRCW: 22.10 (-0.62)

Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST

FRM: 6.38 (-0.12), NEO: 4.57 (-0.04), AU: 9.96 (-0.31), FNHC: 25.34 (+0.89), AMS: 2.53 (unch), NYMX: 0.50 (unch), AMDA: 1.32 (+0.06), CVD: 100.88 (+0.08), GBIM: 6.90 (+0.03), RCAP: 12.54 (-0.42), KBIO: 1.93 (-0.04), COOL: 0.70 (-0.02), SAPE: 24.66 (+0.01), XTLB: 2.45 (-0.13), GERN: 3.16 (-0.01), ANIP: 55.07 (-0.59), BBLU: 1.17 (-0.02), NXTD: 2.24 (+0.02), AP: 17.80 (-0.59), ALQA: 4.94 (-0.06)

ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST

ANIP: 55.07 (-0.59)

ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 55.07 (-0.59)

ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST

ANIP: 55.07 (-0.59)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Drones Propel Precision Agriculture Market's Skyrocketing Growth

Updated Category News Views 2

Transforming Fields with a Bird's Eye View The old-school way of agricultural surveying is about as appealing as a broken plow in a rainstorm. Trudging across miles of farmland, hoping to spot issues before they turn into wallet-drainers—who's got time for that? Enter drones, the buzzing saviors of the modern farm. These high-tech marvels, loaded with multispectral and...

Continue Reading
Syra Health Joins CMS ACCESS Model for Scalable Growth

Updated Category News Views 3

Syra Health Secures Spot in CMS ACCESS Model Every once in a while, a company gets a nod that could redefine its trajectory, and today it’s Syra Health’s turn at bat. Teaming up with HealthSync, they’ve clinched a position in the coveted CMS ACCESS model—a move not just about snagging headlines but potentially securing a golden ticket to a robust revenue stream...

Continue Reading
PowerBank Bags Key Solar Project, Eyes Major Gains

Updated Category News Views 1

A New Milestone for PowerBank Sometimes, out of the blue, a company bags a contract that seems to shift the momentum overnight. That's what's happening with PowerBank Corporation. They've just scored a big win with a contract from SUNY Oneonta to build a 1.6 MW ground-mount solar project. Talk about striking gold in the solar energy field! A Competitive Win Procuring this...

Continue Reading
XTransfer Revs Up Expansion in the UAE Market

Updated Category News Views 2

In the nitty-gritty world of B2B payments, securing a spot in a powerhouse like the UAE is no small potatoes. XTransfer just snagged an in-principle nod from the UAE Central Bank for a Retail Payment Services Licence, and that's got to feel like sweet validation for a company that's aggressively pushing its regulatory map beyond corners it's already conquered. Eyeing the...

Continue Reading
Capricor Faces Lawsuit: Investors Should Take Note

Updated Category News Views 4

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

Continue Reading
Baker Joins AGS: A National Security Powerhouse

Updated Category News Views 0

Andy Baker Moves from the White House to AGS When it rains in national security circles, apparently, it pours. Andy Baker, a name that has been central in U.S. foreign policy during the turbulent Trump administration, has found a new home at American Global Strategies (AGS). He steps into the role of Managing Director, bringing a hefty portfolio of national security...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 2

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading
Mega Matrix Shares Consolidation Ahead: What It Means

Updated Category News Views 5

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

Continue Reading
Travel Smart: Support Wildlife, Avoid Exploitation

Updated Category News Views 1

Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...

Continue Reading
Exploring Before and After School Care Dynamics in PA

Updated Category News Views 1

Navigating the World of Before and After School Care The dad juggling a morning coffee and a laptop at a crowded diner—he’s not just browsing social media; he's flipping through options for his kid’s care. In Harrisburg, PA, before and after school care isn't just babysitting, it’s a lifeline for working parents balancing the chaos of modern schedules. Timothy R....

Continue Reading

Top 5 Most Recently Viewed Articles

SAS Launches Advanced Analytics Solutions for Healthcare Payers

Updated Category News Views 181

SAS Launches Advanced Analytics Solutions for Healthcare Payers New data and analytic products tackle significant health care challenges in medication adherence, record review, reimbursement models, risk management, and cost efficiency. SAS, a frontrunner in data and AI, has introduced an innovative solution named SAS Health Cost of Care Analytics. This product is...

Continue Reading
Kia Recognized with Multiple 2026 Best Cars for Money Awards

Updated Category News Views 93

Kia's Excellence in 2026 Best Cars for Money Awards Kia America recently showcased its commitment to quality and value, winning seven prestigious awards in the 2026 U.S. News & World Report Best Cars for the Money. This recognition emphasizes Kia's dedication to innovative features and exceptional driving experiences across its lineup. A Stellar Lineup of Award-Winning...

Continue Reading
Spar Nord Bank's Extraordinary Meeting Highlights and Changes

Updated Category News Views 159

Key Highlights from Spar Nord Bank's Extraordinary General Meeting Spar Nord Bank A/S held an important extraordinary general meeting recently, marking significant developments within the organization. During this meeting, pivotal resolutions were made that will steer the future direction of the bank. The resolutions were aimed at reshaping both the Board of Directors and...

Continue Reading
Calamos Structured ETFs Offer Cap Rates with Downside Protection

Updated Category News Views 327

Exciting New Cap Rates for Calamos Structured ETFs Calamos Investments LLC is enhancing investment possibilities with the introduction of new cap rates for its structured ETFs. The recent announcement reveals attractive upside cap rates, providing robust coverage for investors seeking exposure to both the S&P 500 and Nasdaq-100 indices. Overview of CPSU and CPNJ Cap Rates...

Continue Reading
An Insightful Look at IES Holdings' Stock Performance

Updated Category News Views 155

Understanding Stock Performance Metrics for IES Holdings In today's market, IES Holdings Inc. has displayed promising stock performance, currently trading at $378.84 due to a 4.81% increase. This impressive rise reflects an overall increase of 8.81% over the last month and a staggering 141.18% over the past year. Such growth invites long-term shareholders to feel...

Continue Reading